Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease.

World journal of gastroenterology - 28 Apr 2015

Chinnadurai Raghavan, Ng Spencer, Velu Vijayakumar, Galipeau Jacques

Abstract excerpt

Utilization of mesenchymal stromal cells (MSCs) for the treatment of Crohn's disease and ulcerative colitis is of translational interest. Safety of MSC therapy has been well demonstrated in early phase clinical trials but efficacy in randomized clinical trials needs to be demonstrated. Understand...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Disease Models, Animal
Share to Inflammatory Bowel Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mesenchymal Stem Cell Transplantation

Share to Mesenchymal Stem Cells

Share to Phenotype

Share to Species Specificity

Source

Open in PubMed Open full text

Identifiers

PMID: 25944991
DOI: 10.3748/wjg.v21.i16.4779
PMCID: PMC4408450

Genes

MSC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25944991-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease.PMID 25944991Read ↗

Advances in mesenchymal stromal cell therapy in the management of Crohn's disease.Semantic proximity Read ↗

Potential methods for improving the efficacy of mesenchymal stem cells in the treatment of inflammatory bowel diseases.Semantic proximity Read ↗

Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology.Semantic proximity Read ↗

Insights into Modeling Inflammatory Bowel Disease from Stem Cell Derived Intestinal OrganoidsSemantic proximity Read ↗

Stem Cell-Based Therapies for Inflammatory Bowel DiseaseSemantic proximity Read ↗

Harnessing murine models of Crohn's disease ileitis to advance concepts of pathophysiology and treatment.Semantic proximity Read ↗

The Use of Potent Populations of Expanded Fetal Human Placental Stromal Cells for the Treatment of Dextran-Sodium-Sulfate Induced Colitis in a Mouse ModelSemantic proximity Read ↗

Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis.Semantic proximity Read ↗

Mesenchymal stem cells ameliorate inflammation in an experimental model of Crohn’s disease via the mesenterySemantic proximity Read ↗

Animal models of inflammatory bowel diseaseSemantic proximity Read ↗

Insights from mouse models of colitis.Semantic proximity Read ↗

Expression of Wnt and Notch signaling pathways in inflammatory bowel disease treated with mesenchymal stem cell transplantation: evaluation in a rat modelSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.